Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...

known as "VIP36," works by binding to the cannabinoid "CB1" receptors on nerve cells found in the body's central and ...

Cannabis is restricted for recreational consumption, but scientific, research and medical applications are allowed. Britain’s ...

Discover how terpenes work synergistically with cannabinoids to enhance medicinal effects, offering therapeutic benefits beyond what CBD and THC provide alone.

If you’re looking for a natural way to relax, recharge, and enhance your daily routine, Mood’s THCa flower might be the solution you’ve been looking for.

Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity. Read the paper ...

Poisonings linked to synthetic and semisynthetic cannabinoids (man-made products designed to mimic cannabis) are increasing ...

Synthetic cannabinoids, a class of new psychoactive substances, bind to cannabinoid receptors CB1 and CB2 much more strongly than tetrahydrocannabinol (THC) and cannabidiol (CBD), raising public ...

known as "VIP36," works by binding to the cannabinoid "CB1" receptors on nerve cells found in the body's central and peripheral nervous systems, much as natural cannabinoids do, and reduce pain ...